Garfield Alastair sold RYTM
July 2, 2025 · Form 4 insider transaction
Garfield Alastair sold 1,313 shares of Rhythm Pharmaceuticals, Inc. at $64.81 per share, a transaction worth $85.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,313
Price
$64.81
Total value
$85.1K
InsiderGarfield Alastair
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 2, 2025
Filing dateJuly 3, 2025
Shares owned after3,132
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on June 25, 2024 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.